serine and tandutinib

serine has been researched along with tandutinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bassères, DS; Bohlander, SK; Davis, RJ; Dayaram, T; Delmotte, MH; Giese, NA; Gilliland, DG; Hiddemann, W; Lokker, N; Radomska, HS; Schnittger, S; Small, D; Sternberg, DW; Tenen, DG; Yamamoto, Y; Zhang, P; Zheng, R	1

Other Studies

1 other study(ies) available for serine and tandutinib

Article	Year
Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. The Journal of experimental medicine, 2006, Feb-20, Volume: 203, Issue:2 Topics: Aged; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cell Line; Enzyme Activation; Female; fms-Like Tyrosine Kinase 3; Granulocytes; Humans; K562 Cells; Leukemia, Myeloid, Acute; Male; MAP Kinase Kinase 1; Myeloid Cells; Phosphorylation; Piperazines; Point Mutation; Quinazolines; Serine; Tumor Cells, Cultured; U937 Cells	2006

Article

Year

Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations.

The Journal of experimental medicine, 2006, Feb-20, Volume: 203, Issue:2

Topics: Aged; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cell Line; Enzyme Activation; Female; fms-Like Tyrosine Kinase 3; Granulocytes; Humans; K562 Cells; Leukemia, Myeloid, Acute; Male; MAP Kinase Kinase 1; Myeloid Cells; Phosphorylation; Piperazines; Point Mutation; Quinazolines; Serine; Tumor Cells, Cultured; U937 Cells

2006